CIK 0001339970 · Non-accelerated filer<br>Smaller reporting company
aTYR PHARMA INC
Sign in to watch- Ticker
- ATYR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 203435077
- Phone
- 8587318389
- Business address
- 10240 SORRENTO VALLEY ROAD, SUITE 300, SAN DIEGO, CA, 92121
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 84 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-06 | Shukla Sanjay President and CEO | Option exercise · Restricted Stock Unit | −1,785 | 0 | ||
| 2021-02-04 | Shukla Sanjay President and CEO | Grant or award · Employee Stock Option (right to buy) | +112,469 | 112,469 | ||
| 2021-02-04 | Shukla Sanjay President and CEO | Grant or award · Employee Stock Option (right to buy) | +120,000 | 120,000 | ||
| 2021-02-04 | DENYES NANCY General Counsel | Grant or award · Employee Stock Option (right to buy) | +45,000 | 45,000 | ||
| 2021-02-04 | Broadfoot Jill Marie Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2020-09-02 | CLARKE JOHN K Director | Sale | −7,260 | $4.01 | $29K | 110,583 |
| 2020-08-28 | CLARKE JOHN K Director | Sale | −100 | $4.00 | $400 | 117,843 |
| 2020-08-27 | CLARKE JOHN K Director | Sale | −5,440 | $4.09 | $22K | 117,943 |
| 2020-08-26 | CLARKE JOHN K Director | Sale | −2,200 | $4.30 | $9K | 123,383 |
| 2020-06-19 | Broadfoot Jill Marie Chief Financial Officer | Purchase | +1,850 | $4.22 | $8K | 9,153 |
| 2020-06-19 | Shukla Sanjay President and CEO | Purchase | +6,000 | $4.27 | $26K | 7,291 |
| 2020-05-26 | Shukla Sanjay President and CEO | Grant or award · Employee Stock Option (right to buy) | +73,142 | 73,142 | ||
| 2020-05-26 | DENYES NANCY General Counsel | Grant or award · Employee Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2020-05-26 | Broadfoot Jill Marie Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2020-05-26 | Shukla Sanjay President and CEO | Grant or award · Employee Stock Option (right to buy) | +80,000 | 0 | ||
| 2020-05-20 | DENYES NANCY General Counsel | Sale | −322 | $3.62 | $1K | 2,735 |
| 2020-05-20 | SCHIMMEL PAUL Director | Sale | −8,447 | $3.64 | $31K | 429,143 |
| 2020-05-16 | DENYES NANCY General Counsel | Option exercise | +892 | 3,057 | ||
| 2020-05-16 | DENYES NANCY General Counsel | Option exercise · Restricted Stock Unit | −892 | 0 | ||
| 2020-05-06 | SCHIMMEL PAUL Director | Grant or award · Stock Option (right to buy) | +1,428 | 1,428 |
Page 8 of 15 · 284 trades